Navigation Links
Protalix BioTherapeutics Sets Record Date for Annual Meeting of Shareholders
Date:11/29/2007

rial-scale production of recombinant therapeutic proteins. Protalix is enrolling and treating patients in its pivotal phase III clinical trial in Israel, the United States and other locations for its lead product candidate, prGCD, for its enzyme replacement therapy for Gaucher disease, a lysosomal storage disorder in humans, and has reached an agreement with the United States Food and Drug Administration on the final design of the pivotal phase III clinical trial through the FDA's Special Protocol Assessment (SPA) process. Protalix is also advancing additional recombinant biopharmaceutical drug development programs.

Safe Harbor Statement:

To the extent that statements in this press release are not strictly historical, all such statements are forward-looking, and are made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk. Factors that might cause such a material difference include, among others, uncertainties related to the ability to attract and retain partners for our technologies and products under development, the identification of lead compounds, the successful preclinical development of our products, the completion of clinical trials, the review process of the FDA, foreign regulatory bodies and other governmental regulation, and other factors described in our filings with the Securities and Exchange Commission. The statements are valid only as of the date hereof and we disclaim any obligation to update this information.

For additional information, contact Protalix BioTherapeutics at: investors@protalix.com


'/>"/>
SOURCE Protalix BioTherapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Protalix BioTherapeutics to Present at UBS Global Life Sciences Conference
2. Protalix BioTherapeutics Announces Public Offering of Common Stock
3. Protalix BioTherapeutics Announces Pricing of Public Offering of Common Stock
4. Protalix BioTherapeutics to Present at CIBC World Markets 18th Annual Healthcare Conference
5. Pieris Validates the Use of Anticalins(R) as Ophthalmologic Biotherapeutics
6. Juvaris BioTherapeutics Announces Six Scientific Presentations at Infectious Diseases Society of America (IDSA) Meeting October 6, 2007
7. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
8. Globus Medical Announces Record 2nd Quarter 2007 Results
9. BioSpace Draws Record Crowd to Chicago Life Science Career Fair
10. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
11. Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...and Awards Celebration has show of ...ly 25 /- With the life sciences posit...ding an advantage amidst global,competition requir...2BUSINESS 2008 Conference and Awards Celebration, ...t edge., The inaugural event will draw some 100 s...
(Date:7/25/2008)...Xinhua-- Over 300 of,China,s top stem...lobe,shared their latest results and held China,s ...nt stem (iPS) cell research during the just,conclu...orum at the China,Medical City complex in Taizhou,...n Hu, Chairman of Beike Biotechnology Co., Ltd., (...
(Date:7/25/2008)...any,s IPLEX(TM) Program in Myotonic ...ly 25 /- Insmed Inc. (Nasda...opharmaceuticals, today,announced that Geoffrey Al...3th Annual Drug Discovery and Development of Innov...t 9:25 AM ET., Dr. Allan will be participating in...
(Date:7/25/2008)...-FirstCall/ -- Insmed Inc. (Nasdaq:,INSM), a devel..., today,announced that it will host a conference c...s its results for the second quarter 2008. Insmed ...ress release before the market,opens on August 8th...ease dial 866-202-1971,(U.S. callers) or 617-213-8...
Breaking Biology Technology:Conference to Turn Scientists of Color into PA-Based Entrepreneurs Set for November 2Conference to Turn Scientists of Color into PA-Based Entrepreneurs Set for November 3Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells 2Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells 3Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells 4Insmed CEO to Present at Drug Discovery & Development Conference 2Insmed to Host Second Quarter 2008 Conference Call 2
...evel protein expression within a variety,of cell...agene , Recombinant adenoviruses provide a versa...escribe the AdEasy adenoviral vector,system, ... viruses. Constructing a recombinant adenoviral,...ss in which the desired,expression cassette is f...
...r RT-PCR using the Absolutely RNA , ...ter Jeff Braman , Stratagene , S...ation kits are , not satisfactory for rev... tested several commercially available RNA ...ontaminating DNA will produce false positive ampli...
...ful method to detect protein interactions in mamma...Stratagene , With Stratagenes mammalian two-hybr...protein-protein interactions via the activation,...s as a result of,reconstitution of a functional ...,two hybrid proteins. It allows researchers to st...
...ferentiated Adipocytes ,,, A new para...i C. Halvorsen ,Zen-Bio, Inc. , Peter Pingerel... , Ligand Pharmaceuticals , Michael R. Briggs ...ne introduces new tools to facilitate the study of...d Adipocytes and Human Differentiated Adipocytes.,...
Other Biology Technology:Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 2Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 3Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 4Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 5Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 6New Kit Generates Exceptionally Pure Total RNA for RT-PCR 2New Kit Generates Exceptionally Pure Total RNA for RT-PCR 3New Kit Generates Exceptionally Pure Total RNA for RT-PCR 4New Kit Generates Exceptionally Pure Total RNA for RT-PCR 5New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 2New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 3New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 4New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 5New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 6New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 7New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 8New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 9Human Primary Preadipocytes and Differentiated Adipocytes 2Human Primary Preadipocytes and Differentiated Adipocytes 3Human Primary Preadipocytes and Differentiated Adipocytes 4Human Primary Preadipocytes and Differentiated Adipocytes 5Human Primary Preadipocytes and Differentiated Adipocytes 6
(Date:7/24/2008)... Stanford, CASteroids bulk up plants just as they...signals that tell the genes to boost growth and de...han in human and animal cells. A new study by plan...merging molecular approach called proteomics to id...nderstanding how these plant hormones activate gen...
(Date:7/24/2008)... Glasses embedded with a telescope promise to mak...ve and do other activities requiring sharper dista...ists describe the advantages of these innovative g...d in the May/June issue of Journal of Biomedical ... month. , "This new design has several advantag...
(Date:7/24/2008)... July 24, 2008 A new study by researchers from C...th addresses one of the most challenging issues in...transmission in poor countries. In these settings...he best outcome for their infants, they should exc...four to six months after birth. But according to t...
(Date:7/24/2008)... Researchers at The Pennsylvania State University...iscovered that the efficacy of imiquimod, a clinic...t antiviral and antitumor activity, is dependent o...r) axis for its action. This discovery, reported ...d Medicine , provides new insights into a widely u...
Breaking Biology News(10 mins):Plant steroids offer new paradigm for how hormones work 2Plant steroids offer new paradigm for how hormones work 3Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Clarient Names Michael J Pellini M D Chief Operating Officer 2845 1Clarient Names Michael J Pellini M D Chief Operating Officer 2845 2Clarient Names Michael J Pellini M D Chief Operating Officer 2845 3Clarient Names Michael J Pellini M D Chief Operating Officer 2845 4Safety Tips for a Fun and Spooky Halloween 2843 1Safety Tips for a Fun and Spooky Halloween 2843 2Prime Therapeutics Announces URAC Accreditation 2840 1Prime Therapeutics Announces URAC Accreditation 2840 2National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 1National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 2National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 3National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 4
...e thought to be essential in helping chemotherapy ...In a new study of chemo patients, scientists at th...Cancer Institute found that 70 percent of subjects...till alive after five years. Patients with normal ... findings raise the possibility of a new strategy ...
...it comes to growing cells in a lab, technique matt... cells grown in three-dimensional cultures use 1,7... in standard two-dimensional petri dishes. , , T...ineering, adds to a growing body of research showi...t cell growth and function. This research shows th...
...te hundreds of families being told their children ...dren may be able to eat peanuts safely, a study by...(UNSW) and Sydney Children,s Hospital has found. ,...ording to the Australasian Society of Clinical Imm...ant finding," said Dr Brynn Wainstein, a Sydney Ch...
...eport, published in the prestigious international ...aecology, found that the rise could not be explain... such as complications in pregnancy or labour/deli..., The research project looked at all births in Wes...0,000 births) and analysed the mode of delivery....
Other Biology News:Gene thought to assist chemo may help cancer thrive 2Gene thought to assist chemo may help cancer thrive 3Growing nerve cells in 3-D dramatically affects gene expression 2Peanut allergies overstated, study finds 2Study shows dramatic increase in Caesarean sections 2
...NA aptamer screening and binding optimization and ...uidic on-chip synthesis platform. These microarray...NA Aptamer Microarray Service. Probe Content Ou...reater than 1500 known aptamer sequences. Add up t...
...prehensive service for custom peptide microarray e...ays synthesized on Paraflo microfluidic chips for ...ibodies or serum samples. This comprehensive servi... binding assays using sample(s) provided by you, s...
...NA aptamer screening and binding optimization and ...uidic on-chip synthesis platform. Thousands of cus...n-chip and LC Sciences can provide assistance with...ilable as part of our comprehensive DNA/RNA Aptame...
...-transferase (GST) is commonly used as a fusion pa... GSTTag sequence has been reported to enhance the ... fusion partners. When expressed in a soluble, pro...urified with immobilized glutathione. Gentle eluti...
Biology Products: